Misplaced Pages

Draft:Dazadrol

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Mo18ekula (talk | contribs) at 15:13, 17 December 2024 (Created page with '{{Infobox drug | drug_name = Dazadrol | image = Dazadrol.svg | width = 250px | caption = <!-- Clinical data --> | pronounce = | tradename = | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = | licence_US = | pregnancy_AU = | pregnancy_category = | dependency_liability = | addiction_liability = | routes_of_administration = | class = | ATC_prefix = | ATC_suffix = <!-- Legal status --> | legal_status = <!-- Pharmaco...'). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 15:13, 17 December 2024 by Mo18ekula (talk | contribs) (Created page with '{{Infobox drug | drug_name = Dazadrol | image = Dazadrol.svg | width = 250px | caption = <!-- Clinical data --> | pronounce = | tradename = | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = | licence_US = | pregnancy_AU = | pregnancy_category = | dependency_liability = | addiction_liability = | routes_of_administration = | class = | ATC_prefix = | ATC_suffix = <!-- Legal status --> | legal_status = <!-- Pharmaco...')(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Dazadrol
Clinical data
Other namesSch 12650
Identifiers
IUPAC name
  • (4-chlorophenyl)-(4,5-dihydro-1H-imidazol-2-yl)-pyridin-2-ylmethanol
CAS Number
ChemSpider
Chemical and physical data
FormulaC15H14ClN3O
Molar mass287.75 g·mol
3D model (JSmol)
SMILES
  • C1CN=C(N1)C(C2=CC=C(C=C2)Cl)(C3=CC=CC=N3)O
InChI
  • InChI=1S/C15H14ClN3O/c16-12-6-4-11(5-7-12)15(20,14-18-9-10-19-14)13-3-1-2-8-17-13/h1-8,20H,9-10H2,(H,18,19)
  • Key:DITYEPYMBCHKLF-UHFFFAOYSA-N

Antidepressant.

Noradrenaline reuptake inhibitor and gastric acid secretion inhibitor.

Synthesis

Patent (Ex 12): #3 substance:

The reaction between p-chlorophenylacetonitrile (1) and 2-bromopyridine (2) in the presence of a suitable base gives (3). Reaction with ethylenediamine forms the imidazoline ring giving PC20361737 (4). Air oxidation then affords the tertiary carbinol by attack at the highly activated, multiply benzylic carbon. There is thus obtained the antidepressant dazadrol (5).

References

  1. Schmitt H, Petillot N. Propriétés pharmacologiques d'un nouvel antidépresseur potentiel: le ((p-chlorophényl)-2-(pyridyl)-hydroxyméthyl) imidazoline (SCH 12.650 . Therapie. 1971 Jul-Aug;26(4):805-21. French. PMID: 5119131.
  2. Lippmann, W. (1970). "Blockade of noradrenaline uptake and inhibition of gastric acid secretion by 2- imidazoline maleate (Sch-12650)". Journal of Pharmacy and Pharmacology. 22 (5): 387–388. doi:10.1111/j.2042-7158.1970.tb08548.x.
  3. Walter Lewis A, DE1905353A1 (1969 to Scherico Ltd).
  4. Lewis A. Walter, US4081544 (1978 to Merck Sharp and Dohme Corp).
  5. Lewis A. Walter, US3932431 (1976 to Merck Sharp and Dohme Corp).

Lua error in Module:Navbox_with_collapsible_groups at line 6: attempt to call field 'with collapsible groups' (a nil value).

Monoamine reuptake inhibitors
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
See also: Receptor/signaling modulatorsMonoamine releasing agentsAdrenergicsDopaminergicsSerotonergicsMonoamine metabolism modulatorsMonoamine neurotoxins
Categories:
Draft:Dazadrol Add topic